Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. A | 21 | 1 | 3 | 1 | €155.90 | €200.06 | 28.324% |
| Resmed Inc. | 19 | 0 | 3 | 0 | €203.40 | €207.72 | 2.122% |
| R1 RCM Inc. | 19 | 0 | 2 | 0 | €11.40 | €17.21 | 50.988% |
| United Therapeutics | 18 | 0 | 3 | 0 | €240.90 | €288.66 | 19.826% |
| Sutro Biopharma Inc | 18 | 0 | 4 | 0 | €3.16 | €11.05 | 249.633% |
| Dexcom Inc. | 18 | 0 | 3 | 0 | €118.04 | €136.82 | 15.912% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.30 | €28.06 | 83.404% |
| Icon plc | 18 | 0 | 6 | 0 | €280.90 | €318.99 | 13.562% |
| Exelixis Inc. | 17 | 0 | 2 | 0 | €20.62 | €25.64 | 24.322% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.70 | - | - |
| Krystal Biotech | 16 | 0 | 3 | 0 | €145.15 | €173.22 | 19.338% |
| Abbott Laboratories | 16 | 0 | 4 | 0 | €98.76 | €116.81 | 18.274% |
| Novo Nordisk A/S ADR | 17 | 1 | 2 | 0 | €116.00 | €130.00 | 12.069% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €12.01 | €22.78 | 89.636% |
| Merit Medical Systems | 16 | 0 | 5 | 0 | €69.50 | €86.90 | 25.032% |
| Pro-Dex Inc. | 15 | 0 | 0 | 0 | €16.60 | - | - |
| Centene Corp. | 15 | 0 | 5 | 0 | €69.30 | €82.57 | 19.149% |
| Cigna Corp. | 15 | 0 | 1 | 0 | €321.20 | €342.03 | 6.484% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €40.40 | €82.93 | 105.275% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €38.20 | €46.08 | 20.635% |
| Bayer AG | 15 | 1 | 0 | 0 | €28.28 | €50.00 | 76.803% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.14 | €10.05 | 143.085% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €161.70 | €215.54 | 33.295% |
| Agilent Technologies Inc. | 17 | 3 | 1 | 1 | €128.20 | €133.66 | 4.260% |
| Halozyme Therapeutics Inc. | 13 | 0 | 2 | 0 | €37.15 | €53.50 | 43.998% |